摘要
背景:阿尔茨海默病(AD)是一种以记忆丧失、神经炎症和氧化应激为特征的神经退行性疾病。β产量过大或清除不足导致其发病聚集和沉积,被认为是AD的主要神经病理标志。因此,降低Aβ水平,抑制Aβ诱导的神经毒性是可行的治疗方法。AD治疗的策略。枸杞传统上被用作天然抗氧化剂和抗衰老产品.然而,枸杞是否具有治疗AD的潜力尚不清楚。 方法:采用荧光透射电子显微镜和透射电子显微镜(TEM)对无果枸杞芽提取物(FWE)对Aβ原纤颤和原纤维解聚的影响进行了测定; Aβ用斑点杂交法检测寡聚体水平,MTT法和TUNEL法检测细胞活力和凋亡。检测Aβ40/42、氧化应激标志物和炎性细胞因子水平。通过相应的工具包。8个月龄的雄性APP/PS1小鼠及其年龄匹配的WT窝群用FWE或车辆口服给药(灌胃),每天4次。然后认知P采用物体识别测试和Y-迷宫测试来确定成绩.用免疫组化和免疫印迹法分别评价A型β负荷和胶质细胞病变。 结果:FWE显著抑制Aβ纤维原纤化,并对Aβ原纤维进行分类,降低Aβ寡聚体水平和Aβ诱导的神经毒性,并在体外减轻氧化应激。 奥诺拉1 Fwe能明显改善APP/PS1小鼠的认知功能,减轻Aβ负荷,减少胶质增生和炎性细胞因子的释放,减轻脑内氧化应激。 结论:Fwe是治疗AD的天然药物。
关键词: 枸杞-芽提取物,阿尔茨海默病,淀粉样蛋白-β,寡聚体,神经炎症,氧化应激。
Current Alzheimer Research
Title:Fruitless Wolfberry-Sprout Extract Rescued Cognitive Deficits and Attenuated Neuropathology in Alzheimer’s Disease Transgenic Mice
Volume: 15 Issue: 9
关键词: 枸杞-芽提取物,阿尔茨海默病,淀粉样蛋白-β,寡聚体,神经炎症,氧化应激。
摘要: Background: Alzheimer’s disease (AD) is a neurodegenerative disease featured by memory loss, neuroinflammation and oxidative stress. Overproduction or insufficient clearance of Aβ leads to its pathological aggregation and deposition, which is considered the predominant neuropathological hallmark of AD. Therefore, reducing Aβ levels and inhibiting Aβ-induced neurotoxicity are feasible therapeutic strategies for AD treatment. Wolfberry has been traditionally used as a natural antioxidant and anti-aging product. However, whether wolfberry species has therapeutic potential on AD remains unknown.
Method: The effects of fruitless wolfberry-sprout extract (FWE) on Aβ fibrillation and fibril disaggregation was measured by thioflavin T fluorescence and transmission electron microscope imaging; Aβ oligomer level was determined by dot-blot; Cell viability and apoptosis was assessed by MTT and TUNEL assay. The levels of Aβ40/42, oxidative stress biomarkers and inflammatory cytokines were detected by corresponding kits. 8-month-old male APP/PS1 mice and their age-matched WT littermates were treated with FWE or vehicle by oral administration (gavage) once a day for 4 weeks. Then the cognitive performance was determined using object recognition test and Y-maze test. The Aβ burden and gliosis was evaluated by immunostaining and immunoblotting, respectively.
Results: FWE significantly inhibited Aβ fibrillation and disaggregated the formed Aβ fibrils, lowered Aβ oligomer level and Aβ-induced neuro-cytotoxicity, and attenuated oxidative stress in vitro. Oral administration of FWE remarkably improved cognitive function, reduced Aβ burden, decreased gliosis and inflammatory cytokines release, and ameliorated oxidative stress in the brains of APP/PS1 mice.
Conclusion: These findings indicate that FWE is a promising natural agent for AD treatment.
Export Options
About this article
Cite this article as:
Fruitless Wolfberry-Sprout Extract Rescued Cognitive Deficits and Attenuated Neuropathology in Alzheimer’s Disease Transgenic Mice, Current Alzheimer Research 2018; 15 (9) . https://dx.doi.org/10.2174/1567205015666180404160625
DOI https://dx.doi.org/10.2174/1567205015666180404160625 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Toxicities by Herbal Medicines with Emphasis to Traditional Chinese Medicine
Current Drug Metabolism Inhibiting the “Undruggable” RAS/Farnesyltransferase (FTase) Cancer Target by Manumycin-related Natural Products
Current Medicinal Chemistry Cetuximab, A Chimeric Anti-Epidermal Growth Factor Receptor Monoclonal Antibody, in Colorectal Cancer Treatment
Current Cancer Therapy Reviews Meet Our Editorial Board Member
Current HIV Research Recent Patents on the Baculovirus Systems
Recent Patents on Biotechnology Genetics of Atherosclerosis in Murine Models
Current Drug Targets Past, Present and Future of Electroanalytical Sensor for Aspirin, Ibuprofen and Paracetamol Detection
Current Pharmaceutical Analysis Medicinal Perspective of Indole Derivatives: Recent Developments and Structure-Activity Relationship Studies
Current Drug Targets Structure, Function and Control of Complement C5 and its Proteolytic Fragments
Current Molecular Medicine Selenium Derivatives as Cancer Preventive Agents
Current Medicinal Chemistry - Anti-Cancer Agents TH2 Cytokines and Associated Transcription Factors as Therapeutic Targets in Asthma
Current Drug Targets - Inflammation & Allergy Alzheimer's Disease and Natural Products: Future Regimens Emerging from Nature
Current Topics in Medicinal Chemistry IPR and Technological Issues Regarding a Biopharmaceutical Formulation -Hemoglobin
Recent Patents on Biotechnology Assessment of Antioxidant Capacity of Natural Products
Current Pharmaceutical Biotechnology A Case of Pantoprazole Anaphylaxis with Cross Reactivity to All Proton Pump Inhibitors: Finding a Safe Alternative
Current Drug Safety Alzheimer’s Disease: New Concepts on the Role of Autoimmunity and NLRP3 Inflammasome in the Pathogenesis of the Disease
Current Neuropharmacology Drug Delivery Systems Using Immobilized Intact Liposomes: A Comparative and Critical Review
Current Drug Delivery Editorial (Thematic Issue: The Link between Alzheimer’s Disease and Down Syndrome. A Historical Perspective)
Current Alzheimer Research LASSBio-542: Novel Thalidomide Analog Distinctly Modulates IL-10 and Inhibits Angiogenesis
Current Bioactive Compounds Parkinson's Disease: A Role for the Immune System
Current Molecular Pharmacology